Aminoglutethimide treatment in advanced breast cancer: An efficient therapy as a late endocrine alternative in a sequential therapeutic approach
- 1 March 1983
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 3 (1), 73-76
- https://doi.org/10.1007/bf01806236
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.BMJ, 1981
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Suppression of estrogens with Aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: A reviewBreast Cancer Research and Treatment, 1981
- Treatment of metastatic breast cancer with aminoglutethimideCancer, 1981
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978
- PANCYTOPENIA INDUCED BY AMINOGLUTETHIMIDE IN TREATMENT OF BREAST-CANCER1978
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977
- Medical and surgical adrenalectomy in patients with advanced breast carcinomaCancer, 1977
- Aminoglutethimide (Elipten-Ciba) as an Inhibitor of Adrenal Steroidogenesis: Mechanism of Action and Therapeutic TrialJournal of Clinical Endocrinology & Metabolism, 1967
- Bilateral Adrenalectomy in the Treatment of Cancer of the BreastArchives of Surgery, 1955